CORORA

Swiss trademark · 452552 · Word mark · In force

Register entry

Registration number
452552
Application number
01175/1998
Status
In force
Type
Word mark
Filed
Feb 13, 1998
Registered
Jun 29, 1998
Published
Jul 27, 1998
Protected until
Feb 13, 2028
Priority
18.08.1997 US
Remarks
Teilpriorität; detaillierte Angaben im Aktenheft.
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, einschliesslich Pharmazeutika für die Abstimmung des Gewichtsverlusts, für die Regulierung der Reproduktionsfunktion, für die Förderung der Wundheilung und für den Gebrauch in der Behandlung von Obesität, Diabetes, Hypertonie, Dislipidemie, cardiovaskulären Erkrankungen und Infertilität.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Feb 24, 2017

    Renewed

    Published in Swissreg on 24.02.2017

  3. Mar 3, 2008

    Holder’s address changed

    Owner
    Amgen Inc., 1840 DeHavilland Drive, Thousand Oaks (CA 91320-1789), USA → Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1789, USA

    Published in the SOGC no. 43 of 03.03.2008

  4. Feb 25, 2008

    Renewed

    Published in the SOGC no. 38 of 25.02.2008

  5. Dec 3, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patentanwälte, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 234 of 03.12.2007

  6. Jul 27, 1998

    Registered

    Published in the SOGC no. 142 of 27.07.1998

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.